Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $0.62 in the prior trading day, Unicycive Therapeutics Inc (NASDAQ: UNCY) closed at $0.55, down -11.59%. In other words, the price has decreased by -$11.59 from its previous closing price. On the day, 1.8 million shares were traded.
Ratios:
Our goal is to gain a better understanding of UNCY by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.28 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on April 21, 2025, initiated with a Buy rating and assigned the stock a target price of $6.
On April 04, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $9.
Stock Price History:
Over the past 52 weeks, UNCY has reached a high of $1.16, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -7.12%, while the 200-Day Moving Average is calculated to be 2.90%.
Shares Statistics:
A total of 113.84M shares are outstanding, with a floating share count of 100.03M. Insiders hold about 17.08% of the company’s shares, while institutions hold 52.16% stake in the company.
